Dr. Jayan Nair, M.D.
What this data tells you about Dr. Nair
Dr. Jayan Nair is a medical oncology in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Nair performed 25,136 Medicare services across 2,282 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nair received a total of $6,056 from 55 pharmaceutical and/or device companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nair is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 17,850 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 1,820 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 960 | $19 | $51 |
| Blood draw (venipuncture) | 616 | $8 | $9 |
| Dexamethasone injection (steroid) | 607 | $0 | $3 |
| Complete blood count (CBC) with differential | 604 | $8 | $29 |
| Initial hospital admission, high complexity | 328 | $135 | $556 |
| Office visit, established patient (30-39 min) | 306 | $99 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 270 | $1 | $28 |
| Hospital follow-up visit, moderate complexity | 188 | $62 | $188 |
| Drug injection, under skin or into muscle | 180 | $11 | $69 |
| Injection of additional new drug or substance into vein | 169 | $12 | $61 |
| Office visit, established patient, complex (40-54 min) | 168 | $139 | $474 |
| Anti-nausea injection (ondansetron/Zofran) | 164 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 95 | $99 | $378 |
| Red blood count automated, with additional calculations | 90 | $5 | $20 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 86 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 82 | $49 | $189 |
| Office visit, established patient (20-29 min) | 65 | $70 | $239 |
| Hospital follow-up visit, high complexity | 62 | $93 | $260 |
| Injection, diphenhydramine hcl, up to 50 mg | 57 | $1 | $3 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 49 | $3 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 48 | $16 | $56 |
| Initial hospital admission, moderate complexity | 38 | $102 | $373 |
| Administration of chemotherapy into vein, each additional hour | 35 | $22 | $79 |
| Injection of drug or substance into vein | 33 | $28 | $156 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 26 | $25 | $82 |
| Infusion into a vein for hydration, each additional hour | 25 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 23 | $22 | $84 |
| Administration of additional new drug or substance into vein, 1 hour or less | 23 | $49 | $178 |
| New patient office visit, complex (60-74 min) | 23 | $173 | $585 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $18 | $59 |
| Infusion, normal saline solution , 1000 cc | 17 | $2 | $7 |
| New patient office visit (45-59 min) | 11 | $131 | $453 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nair is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nair experienced with iron infusion (feraheme)?
Does Dr. Nair receive payments from pharmaceutical companies?
How do Dr. Nair's costs compare to other medical oncologys in Sarasota?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology